Why Is My Fasting Insulin Normal but I Still Feel Awful?

Why Is My Fasting Insulin Normal but I Still Feel Awful?

For most people, a fasting insulin result inside the lab reference range does not mean insulin signaling is working optimally. Research and clinical practice increasingly distinguish between 'normal' (the wide range labs use to avoid flagging half the population) and 'optimal' (the narrower range associated with low metabolic disease risk). If your number is between 5–15 µIU/mL but you feel terrible, the issue is usually a combination of reference-range width, post-meal insulin behavior that fasting tests miss entirely, and co-occurring imbalances that a single biomarker cannot capture.

What the Optimal Fasting Insulin Range Actually Looks Like

Most commercial labs flag fasting insulin as abnormal only above 24–25 µIU/mL. In research contexts, however, insulin resistance correlates with risk at far lower thresholds. A landmark analysis published in the Journal of Clinical Endocrinology & Metabolism found that cardiovascular risk rose incrementally at fasting insulin levels above roughly 7–9 µIU/mL in non-diabetic adults, well below the upper limit on standard panels (Després et al., JCEM 1996; PMID: 8772579).

Functional medicine practitioners and metabolic researchers commonly use an optimal target of below 8 µIU/mL fasting — and some set the ceiling at 6 µIU/mL for people who want to minimize long-term risk. If your result is 11 µIU/mL, it is technically 'in range,' but it sits in a zone that warrants investigation, especially when symptoms are present.

This gap between 'normal' and 'optimal' is why understanding what causes fasting insulin to be out of range matters even when your number is technically passing.

It is also worth noting that the reference range itself was derived from population averages that include overweight and sedentary individuals — meaning a large proportion of the 'normal' population already has some degree of metabolic dysregulation baked into the baseline. A fasting insulin of 15 µIU/mL is statistically common; it is not physiologically ideal.

Why a Single Fasting Number Misses So Much

Fasting insulin is a snapshot taken when your body is in its most quiescent metabolic state — not when it is being challenged. Studies using oral glucose tolerance tests (OGTT) with insulin measurements at 30, 60, and 120 minutes repeatedly show that a substantial proportion of people with entirely normal fasting insulin exhibit hyperinsulinemia during the post-meal window (Tabák et al., Diabetologia 2009; PMID: 19455320). That post-meal spike is where the damage accumulates: repeated high insulin exposure drives receptor downregulation, promotes fat storage, and feeds a cycle of energy crashes and cravings — all while your fasting number sits quietly in the 'normal' box.

In the Tabák study, individuals who progressed to type 2 diabetes over a 10-year follow-up showed markedly elevated 2-hour post-load insulin values years before their fasting insulin crossed any clinical threshold. The post-meal window, not the fasting draw, was the earliest detectable signal of trouble.

There are at least four other reasons a fasting number can look fine while you feel awful:

1. Time of draw matters. Insulin has a short half-life. Stressful morning commutes, poor sleep the night before, or even a 10-hour fast vs. a 14-hour fast can shift results by several units.
2. HOMA-IR tells more than insulin alone. The homeostatic model assessment for insulin resistance (HOMA-IR) multiplies fasting insulin by fasting glucose and divides by a constant. A HOMA-IR above 1.9 is considered borderline; above 2.9, impaired. Two people with identical fasting insulin can have meaningfully different HOMA-IR scores if their fasting glucose differs.
3. Inflammation blunts the signal differently. Elevated CRP or IL-6 can impair intracellular insulin signaling even when circulating insulin levels appear normal — specifically by interfering with IRS-1 phosphorylation downstream of the insulin receptor. If you've ever wondered why CRP can be normal but you still feel awful, this overlap is part of the story.
4. Other hormones compound the picture. Cortisol, thyroid hormones, and sex hormones all modulate insulin sensitivity. A woman in perimenopause with declining estrogen may have perfectly 'normal' fasting insulin but dramatically worse glucose tolerance than she had a decade ago — because estrogen normally enhances GLUT4 expression in muscle tissue.

Symptoms of High Fasting Insulin (Even When Labs Say Normal)

If your fasting insulin trends toward the upper end of the reference range — or if your HOMA-IR is elevated even with a 'normal' fasting result — you may recognize several of the following:

• Persistent fatigue that does not resolve with adequate sleep
• Brain fog, especially in the mid-morning or mid-afternoon
• Strong, rapid-onset carbohydrate cravings — the kind that feel physically urgent
• Difficulty losing weight despite reasonable calorie intake
• Energy crashes 1–2 hours after meals
• Elevated triglycerides on a lipid panel, even with normal LDL
• Acanthosis nigricans — darkened skin folds at the neck or armpits (a later sign)
• Increased hunger shortly after eating
• Elevated blood pressure without an obvious dietary cause — hyperinsulinemia stimulates renal sodium retention and sympathetic nervous system tone, both of which raise blood pressure independently of sodium intake

A large prospective study in Diabetes Care showed that people in the highest quartile of fasting insulin — still technically 'in range' — were more than twice as likely to develop type 2 diabetes over a 10-year period compared with those in the lowest quartile (Hanson et al., Diabetes Care 2002; PMID: 12196432). Symptoms often precede diagnosis by years.

It is also worth knowing that what an optimal fasting insulin level looks like in relation to your glucose trend and other cardiometabolic markers gives you more actionable information than either biomarker in isolation.

Why Cravings Can Feel So Intense — and What's Actually Driving Them

The question 'why do my cravings feel so intense, like I'll implode if I don't get what I want?' comes up constantly in communities discussing insulin and blood sugar. This is not a willpower failure — it is neurobiology.

When insulin signaling is dysregulated, glucose uptake into neurons can become intermittently impaired. The brain, which is almost entirely glucose-dependent, responds to perceived fuel shortage with a drive state that overrides rational thinking. Dopamine circuits involved in reward-seeking activate strongly, and the urgency feels chemical — because it is (Figlewicz & Benoit, Physiology & Behavior 2009; PMID: 19446573).

Several factors amplify this:

• Reactive hypoglycemia: A spike-and-crash pattern means blood sugar can drop to the low-normal or sub-normal range, triggering a stress hormone response (cortisol, adrenaline) that creates intense urgency for fast carbohydrates. The cortisol spike itself further worsens insulin resistance over the following hours, creating a self-reinforcing cycle.
• ADHD overlap: Executive function depends heavily on stable prefrontal cortex glucose supply and dopamine tone. People with ADHD already have lower baseline dopamine signaling, so blood sugar crashes hit harder. The impulsivity that's characteristic of ADHD converges with metabolic urgency to make cravings feel completely overwhelming. This is a recognized clinical overlap, not a personal weakness. Neuroimaging research has shown that prefrontal glucose metabolism is already attenuated in ADHD, meaning any additional metabolic stressor — a post-meal glucose crash, poor sleep, or reactive hypoglycemia — disproportionately impairs inhibitory control.
• Sleep debt: Even one night of poor sleep raises insulin resistance markers and ghrelin (hunger hormone), compounding the craving cycle. A controlled crossover trial published in the Annals of Internal Medicine showed that restricting sleep to 5.5 hours increased appetite for high-carbohydrate, calorie-dense foods by 23–45% compared with 8.5 hours, independent of total caloric intake (Nedeltcheva et al., Annals of Internal Medicine 2010; PMID: 20921542).

If you're noticing that cravings track with ADHD symptom flares, your insulin story may be worth investigating beyond a single fasting draw. Pairing it with a full glucose tolerance test — ideally with insulin measurements at each interval — gives a much more complete picture. You can also review what causes high fasting insulin for evidence-based next steps.

Symptoms of Low Fasting Insulin

While most of this article addresses dysregulation trending high, low fasting insulin (typically below 2–3 µIU/mL) is also clinically meaningful and often overlooked:

• Unexplained weight loss or difficulty maintaining weight
• Polydipsia and polyuria (excessive thirst and urination) — classic early signs in type 1 or LADA
• Fatigue with a different character — not sluggish, but weak and jittery
• Ketosis tendency even outside fasting or ketogenic diet contexts
• Erratic glucose levels that swing wide without obvious dietary cause

Very low fasting insulin alongside elevated fasting glucose should prompt urgent evaluation for autoimmune pancreatic dysfunction (LADA — latent autoimmune diabetes in adults). LADA accounts for approximately 5–10% of all diabetes diagnoses and is more common in adults over 30 than widely appreciated, often presenting initially as apparent type 2 diabetes but with a more rapid progression to insulin dependence. The distinguishing antibody test is GAD65 (glutamic acid decarboxylase antibody) — a simple add-on to a standard metabolic panel that most physicians will order on request. If your fasting glucose is also elevated, see why fasting glucose can stay high for a breakdown of the mechanistic pathways.

Does It Matter If Everything Else on Your Panel Looks Normal?

Yes — and a detailed answer to that question is worth reading in full, because the interaction between fasting insulin and other biomarkers is where most of the clinical insight lives. When fasting insulin is the only thing that looks off, the pattern still predicts future cardiometabolic risk with meaningful statistical power.

A meta-analysis published in Diabetologia found that elevated fasting insulin predicted incident type 2 diabetes independently of fasting glucose, BMI, and lipid levels (Manco et al., Diabetologia 2010; PMID: 20157669). In other words, 'normal' on every other marker does not neutralize what a trending insulin number is telling you.

HDL cholesterol deserves special mention here. Hyperinsulinemia suppresses hepatic apolipoprotein A-I synthesis — the structural protein of HDL particles — which is why an HDL below 50 mg/dL combined with a fasting insulin above 10 µIU/mL and triglycerides above 100 mg/dL forms a triad that many metabolic researchers treat as a soft diagnosis of insulin resistance even without a formal HOMA-IR calculation.

What to Do When Insulin Looks Normal but Symptoms Persist

Here is a practical prioritization framework:

1. Request a HOMA-IR calculation — most physicians will calculate this if you ask; you can also compute it yourself: (fasting insulin × fasting glucose) / 405 (if glucose is in mg/dL).
2. Ask for a 2-hour post-glucose insulin — a 75g OGTT with insulin drawn at 0, 60, and 120 minutes reveals post-meal hyperinsulinemia that fasting tests miss.
3. Review your lipid panel for elevated triglycerides and low HDL — this pattern correlates with insulin resistance even when fasting insulin looks acceptable.
4. Audit sleep quality and cortisol exposure — overnight cortisol elevation from poor sleep raises morning insulin resistance and can make every number look slightly worse than your baseline.
5. Track cravings timing and intensity relative to meals — a craving spike 60–90 minutes after eating points toward reactive patterns worth discussing with a provider.
6. Consider inflammatory load — persistent low-grade inflammation impairs receptor sensitivity even at normal circulating insulin levels.
7. Get a GAD65 antibody test if insulin is low-normal and glucose is trending up — ruling out LADA early changes the treatment trajectory significantly.

What This Means for Your Formula

When Ones analyzes a user's lab results and health data, fasting insulin is interpreted against HOMA-IR context, symptom patterns, glucose trend, and relevant biomarkers — not just against standard lab reference ranges. If the data points toward impaired insulin sensitivity or a trending pattern, the formula may include:

• Berberine — one of the most studied plant-derived insulin sensitizers, with a 2012 meta-analysis in Metabolism examining 14 randomized controlled trials (n = 1,068 patients) demonstrating fasting glucose reductions of approximately 15.5 mg/dL and fasting insulin reductions of 2.33 µIU/mL compared with placebo — outcomes comparable to metformin in early metabolic dysfunction (Dong et al., Metabolism 2012; PMID: 22539358). Berberine's primary mechanism is AMPK activation, which upregulates GLUT4 translocation to the cell membrane independently of insulin receptor binding. Ones doses berberine at clinically relevant levels aligned with the trials.
• Omega-3 (EPA/DHA) — EPA and DHA reduce hepatic triglyceride synthesis and improve adipocyte insulin sensitivity by modulating PPARγ activity and reducing inflammatory eicosanoid production. A consistent body of evidence, including large-scale cardiovascular outcome trials, supports omega-3s as a foundation for cardiometabolic support. Ones sources EPA/DHA from triglyceride-form fish oil with third-party oxidation testing.
• Magnesium Glycinate — magnesium is a required cofactor for the insulin receptor tyrosine kinase reaction — the first intracellular step in insulin signaling after the receptor is occupied. Dietary magnesium deficiency independently predicts insulin resistance in epidemiological cohorts, and supplemental magnesium at 382 mg/day over 16 weeks has been shown to improve HOMA-IR by approximately 0.6 units in deficient populations compared with placebo (Guerrero-Romero et al., Diabetes & Metabolism 2004; PMID: 15207461). Ones includes magnesium in its bioavailable glycinate form when intake gaps are identified.

The goal is always a formula calibrated to what your specific data shows — not a generic metabolic stack applied to everyone who mentions fatigue.

Key Takeaways

• A fasting insulin result inside the standard lab range can still reflect suboptimal metabolic function — research-based optimal is below 6–8 µIU/mL, not the lab's upper limit of ~25, and that reference range was built from a population that already includes many metabolically compromised individuals.
• HOMA-IR and post-meal insulin testing reveal patterns that a single fasting draw cannot detect — post-load hyperinsulinemia at 60 minutes is often the earliest measurable signal of future metabolic disease.
• Intense cravings, brain fog, energy crashes, and fatigue are recognizable symptoms of insulin dysregulation even when fasting numbers look acceptable — the biology is neurochemical, not a willpower issue.
• ADHD and insulin dysregulation overlap through dopamine signaling and prefrontal glucose metabolism, which amplifies the urgency of cravings beyond what either condition produces alone.
• Low fasting insulin is also clinically significant; a GAD65 antibody test can rule out LADA, which is frequently misdiagnosed as type 2 diabetes in adults.
• Berberine (AMPK-mediated GLUT4 activation), omega-3 fatty acids (PPARγ modulation and triglyceride reduction), and magnesium glycinate (insulin receptor kinase cofactor) have the strongest evidence base for supporting insulin sensitivity at clinically validated doses — meaningful only when personalized to your specific lab picture.